Deborah Gater

Summary

Affiliation: Thomson Reuters
Country: UK

Publications

  1. ncbi American Chemical Society--238th National Meeting & Exposition. Developments in medicinal chemistry: part 1. 16-20 August 2009, Washington DC, USA
    Deborah Gater
    Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK
    IDrugs 12:605-7. 2009
  2. ncbi American Chemical Society--238th National Meeting & Exposition. Developments in medicinal chemistry: part 2. 16-20 August 2009, Washington DC, USA
    Deborah Gater
    Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK
    IDrugs 12:608-11. 2009
  3. ncbi 32nd National Medicinal Chemistry Symposium--medicinal chemistry developments for neurodegeneration, diabetes and cancer
    Deborah Gater
    Thomson Reuters, London, UK
    IDrugs 13:514-6. 2010
  4. ncbi 32nd National Medicinal Chemistry Symposium--medicinal chemistry developments for cancer, and cardiovascular, metabolic and psychiatric disorders
    Deborah Gater
    Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK
    IDrugs 13:517-9. 2010

Collaborators

Detail Information

Publications4

  1. ncbi American Chemical Society--238th National Meeting & Exposition. Developments in medicinal chemistry: part 1. 16-20 August 2009, Washington DC, USA
    Deborah Gater
    Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK
    IDrugs 12:605-7. 2009
    ....
  2. ncbi American Chemical Society--238th National Meeting & Exposition. Developments in medicinal chemistry: part 2. 16-20 August 2009, Washington DC, USA
    Deborah Gater
    Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK
    IDrugs 12:608-11. 2009
    ....
  3. ncbi 32nd National Medicinal Chemistry Symposium--medicinal chemistry developments for neurodegeneration, diabetes and cancer
    Deborah Gater
    Thomson Reuters, London, UK
    IDrugs 13:514-6. 2010
    ....
  4. ncbi 32nd National Medicinal Chemistry Symposium--medicinal chemistry developments for cancer, and cardiovascular, metabolic and psychiatric disorders
    Deborah Gater
    Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK
    IDrugs 13:517-9. 2010
    ..5 ion channel antagonists; and the discovery of the VEGFR2 kinase inhibitor AMG-429 (Amgen Inc)...